Good Therapeutics
Develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Launch date
Employees
Market cap
-
Enterprise valuation
€50m (Public information from Dec 2021)
Seattle Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$11.2m | Series A | ||
* | $11.0m | Series A | |
* | $8.0m Valuation: $55.0m | Series B | |
* | $250m | Acquisition | |
| Total Funding | €27.5m | ||
Related Content
Recent News about Good Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
